WallStreetZenWallStreetZen

How to Buy Veradigm Stock

Veradigm Inc

Allscripts Healthcare Solutions, Inc. , together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.

Veradigm stock last closed at $12.89, down 0.69% from the previous day, and has decreased 40.41% in one year. It has underperformed other stocks in the Health Information Services industry by 0.03 percentage points. Veradigm stock is currently +1.98% from its 52-week low of $12.64, and -44.56% from its 52-week high of $23.25.

At the moment, there are 109.26M MDRX shares outstanding. The market value of MDRX is $1.41B. In the last 24 hours, 2.42M MDRX shares were traded.

How to Buy Veradigm Stock

Not sure how to invest in Veradigm stock? Here's how.
  1. Choose where to buy Veradigm stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you figure out where to buy Veradigm stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Put funds into your investment account: Select your method of payment and add your info.
  4. Research Veradigm stock: The Veradigm ticker symbol is MDRX. Is Veradigm stock a good investment? Should you buy shares of MDRX? How do MDRX's underlying business fundamentals look? Do top analysts think Veradigm is a good buy? Why has MDRX's stock price moved recently? (Hint: Our stock market research tools can help you understand if MDRX is a good stock to buy).
  5. Make your MDRX buy order: Decide if you will purchase MDRX shares at the current market price or use a limit order to purchase MDRX stock at a particular price.
  6. Keep tabs on your investment in MDRX: Create a watchlist to get live updates on your new investment in Veradigm stock.

Step 1: Choose where to buy Veradigm stock

You will need a brokerage account to access the NASDAQ market and buy MDRX stock.

A brokerage account allows you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our experience, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to global financial markets: From Technology to Industrials, New York to London — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your share purchase by signing up for an account with eToro today.

Open eToro Account

Step 2: Open your brokerage account

Now that you've chosen the right brokerage, it's time to fill out some personal details so you are able to buy MDRX today.

How to Start a New Brokerage Account on eToro

  1. Click here to get started.
  2. Enter your personal details to start your new trading account.
  1. Submit your details by pressing the "Create Account" button.
Get started with eToro today

Step 3: Put funds into your investment account

Now that you've finished signing up on the best app for stock investing, your next step is to transfer the money for your investment:

Watch the tutorial below to see the process of depositing funds into your new brokerage account.

Get started with eToro today

Step 4: Research Veradigm stock

After you have identified the best place to buy Veradigm stock, it's very important to analyze their stock before you buy, so you truly understand the risk as well as the upside.

Veradigm stock data

MDRX Price
$12.89
1w %
-3.88%
1y %
-40.41%
5y %
4.97%
P/E
28.64x
P/B
1.2x
P/S
1.68x
PEG
0.57x
Revenue
$837.19M
Earnings
$60.63M
Fore. Rev. Growth
-21.49%
Fore. Earn. Growth
62.22%
Market Cap
$1.41B
Next Earnings
May 3, 2023
Next Dividend
N/A

Fundamentals of MDRX

WallStreetZen was created to help average investors perform more accurate fundamental analysis in less time.

You can see all of the due diligence checks on MDRX's stock page.

Is MDRX stock properly valued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge MDRX's fair value.

Using relative valuations ratios:

  • MDRX could be overvalued based on its P/E ratio of 28.64x, relative to Health Information Services industry P/E ratio of 4.31x
  • MDRX could be undervalued based on its P/B ratio of 1.2x, relative to Health Information Services industry P/B ratio of 3.44x
  • MDRX may be undervalued based on its PEG ratio of 0.57x

You can access additional valuation research on MDRX's stock here.

MDRX Financials at a glance

Positive Health Checks:

  • MDRX earnings of $78.13M is not enough to cover its interest payments.
  • MDRX's operating cash flow of $160.81M allows it to safely service it's debt of $218.81M.
  • There are more short-term assets than short-term liabilities on the MDRX balance sheet.
  • There are more short-term assets than long-term liabilities on the MDRX balance sheet.
  • Total MDRX debt is lower than 5 years ago, relative to shareholder equity.

Negative Health Checks:

  • MDRX profit margin has gone down from 96.2% to 7.2% in the past year.
  • MDRX has a relatively high debt to equity ratio of 0.44.

Is Veradigm stock a Buy, Hold, or Sell, according to analysts?

Out of 6 Equities analysts who monitor MDRX, the consensus analyst rating on MDRX is a Hold

Please note that analyst ratings are not stock recommendations, nor are they financial advice.

Most Recent MDRX Analyst Recommendations

Jessica Tassan, a top 27% analyst from Piper Sandler downgrades MDRX to a hold rating and raises their MDRX price target from $17.00 to $18.50, on Feb 1, 2023.

Jasper Hellweg, a top 10% analyst from Argus Research upgrades MDRX to a strong buy rating and announces their MDRX price target of $26.00, on Dec 7, 2022.

Anne Samuel, a top 29% analyst from JP Morgan maintains MDRX with a strong sell rating and raises their MDRX price target from $19.00 to $20.00, on Nov 18, 2022.

Cindy Motz, a bottom 23% analyst from Goldman Sachs upgrades MDRX to a strong buy rating and raises their MDRX price target from $22.00 to $23.00, on Nov 9, 2022.

Scott Schoenhaus, a bottom 23% analyst from KeyBanc initiates coverage on MDRX with a hold rating, on Sep 16, 2022.

You can dig deeper into what analysts are projecting on the Veradigm stock forecast page.

Metrics for Advanced MDRX Traders

SMA10
13.33
SMA20
14.25
SMA50
16.41
SMA100
17.03
SMA200
16.42
MACD
-1.02
MACD Signal
-1
MACD Histogram
-0.03
RSI
25.63
Stochastic %K
9.08
Stochastic %D
7
StochRSI %K
53.44
StochRSI %D
41.46

How are MDRX Revenues/Earnings doing?

Last year, MDRX earnings were $60.63M. During the last 3 year, MDRX's earnings have gone up by -84.91% per year. This was slower than the Health Information Services industry average of 35.89%.

Last year, MDRX revenue was $837.19M. During the past 5 year, MDRX's revenue has grown by -11.6% per year. This was slower than the Health Information Services industry average of 42.22%.

Find out more about MDRX's earnings and revenue performance here.

Who is buying/selling MDRX?

In the past 12 months, executives and large shareholders at MDRX have sold more shares than they have bought.

Richard J. Poulton, CEO of MDRX, was the latest MDRX insider to sell. They sold $349,680.36 worth of MDRX stock on Mar 2, 2023.

Dig into more about who owns MDRX shares here.

Does MDRX stock generate passive income?

No, Veradigm doesn't provide an income stream by paying out dividends.

What do other investors have to say about MDRX?

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Make your MDRX buy order

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at an exact dollar amount, place a limit order.

Press the Open Trade button and your broker will place the order.

If you need additional help with investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Keep tabs on your investment in MDRX

Now that you own some MDRX stock, you'll want to stay up-to-date on your new investment.

Make a watchlist to keep tabs on your MDRX stock.

MDRX Feed

How to Buy Stock in Veradigm

To summarize, here are the 6 steps for buying Veradigm stock:

  1. Choose where to buy Veradigm stock
  2. Open your brokerage account
  3. Put funds into your investment account
  4. Research Veradigm stock
  5. Make your MDRX buy order
  6. Keep tabs on your investment in MDRX

If you need a brokerage, eToro is our recommended option.

Get Started with eToro Today

If you would like to track your investment in Veradigm, create your watchlist below.

NASDAQ: MDRX
$12.89-0.09 (-0.69%)
Updated Mar 23, 2023
Open eToro Account
NASDAQ: MDRX
$12.89-0.09 (-0.69%)
Updated Mar 23, 2023
Open eToro Account

FAQ

How much does it cost to buy one Veradigm share?

As of Mar 23, 2023, it costs $12.89 to buy one share of Veradigm stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $6, you can buy 0.465 shares of MDRX.

Get Started with eToro Today

Is now a good time to buy Veradigm stock?

According to 6 Wall Street analysts who monitor Veradigm, their consensus recommendation is to hold Veradigm stock.

What is the best way to buy Veradigm stock?

One way to place an order for Veradigm stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.